143 related articles for article (PubMed ID: 15361543)
1. Using molecular tools to dissect the role of Galphas in sensitization of AC1.
Vortherms TA; Nguyen CH; Berlot CH; Watts VJ
Mol Pharmacol; 2004 Dec; 66(6):1617-24. PubMed ID: 15361543
[TBL] [Abstract][Full Text] [Related]
2. D2 dopamine receptor-induced sensitization of adenylyl cyclase type 1 is G alpha(s) independent.
Vortherms TA; Nguyen CH; Bastepe M; Jüppner H; Watts VJ
Neuropharmacology; 2006 Apr; 50(5):576-84. PubMed ID: 16376953
[TBL] [Abstract][Full Text] [Related]
3. Heterologous sensitization of recombinant adenylate cyclases by activation of D(2) dopamine receptors.
Cumbay MG; Watts VJ
J Pharmacol Exp Ther; 2001 Jun; 297(3):1201-9. PubMed ID: 11356947
[TBL] [Abstract][Full Text] [Related]
4. Dexras1 blocks receptor-mediated heterologous sensitization of adenylyl cyclase 1.
Nguyen CH; Watts VJ
Biochem Biophys Res Commun; 2005 Jul; 332(3):913-20. PubMed ID: 15913563
[TBL] [Abstract][Full Text] [Related]
5. Regulation of responsiveness at D2 dopamine receptors by receptor desensitization and adenylyl cyclase sensitization.
Bates MD; Senogles SE; Bunzow JR; Liggett SB; Civelli O; Caron MG
Mol Pharmacol; 1991 Jan; 39(1):55-63. PubMed ID: 1846220
[TBL] [Abstract][Full Text] [Related]
6. Sensitization of adenylate cyclase by Galpha i/o-coupled receptors.
Watts VJ; Neve KA
Pharmacol Ther; 2005 Jun; 106(3):405-21. PubMed ID: 15922020
[TBL] [Abstract][Full Text] [Related]
7. D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor.
Jarrahian A; Watts VJ; Barker EL
J Pharmacol Exp Ther; 2004 Mar; 308(3):880-6. PubMed ID: 14634050
[TBL] [Abstract][Full Text] [Related]
8. Novel regulatory properties of human type 9 adenylate cyclase.
Cumbay MG; Watts VJ
J Pharmacol Exp Ther; 2004 Jul; 310(1):108-15. PubMed ID: 14996950
[TBL] [Abstract][Full Text] [Related]
9. Short- and long-term regulation of adenylyl cyclase activity by delta-opioid receptor are mediated by Galphai2 in neuroblastoma N2A cells.
Zhang L; Tetrault J; Wang W; Loh HH; Law PY
Mol Pharmacol; 2006 Jun; 69(6):1810-9. PubMed ID: 16525132
[TBL] [Abstract][Full Text] [Related]
10. Sensitization of neuronal A2A adenosine receptors after persistent D2 dopamine receptor activation.
Vortherms TA; Watts VJ
J Pharmacol Exp Ther; 2004 Jan; 308(1):221-7. PubMed ID: 14566008
[TBL] [Abstract][Full Text] [Related]
11. Partial rescue of functional interactions of a nonpalmitoylated mutant of the G-protein G alpha s by fusion to the beta-adrenergic receptor.
Ugur O; Onaran HO; Jones TL
Biochemistry; 2003 Mar; 42(9):2607-15. PubMed ID: 12614155
[TBL] [Abstract][Full Text] [Related]
12. Assays for G-protein-coupled receptor signaling using RGS-insensitive Galpha subunits.
Clark MJ; Traynor JR
Methods Enzymol; 2004; 389():155-69. PubMed ID: 15313565
[TBL] [Abstract][Full Text] [Related]
13. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II-evoked enhanced expression of RGS2 attenuates Gi-mediated adenylyl cyclase signaling in A10 cells.
Li Y; Hashim S; Anand-Srivastava MB
Cardiovasc Res; 2005 Jun; 66(3):503-11. PubMed ID: 15914115
[TBL] [Abstract][Full Text] [Related]
15. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells.
Clark MJ; Traynor JR
J Pharmacol Exp Ther; 2005 Feb; 312(2):809-15. PubMed ID: 15383633
[TBL] [Abstract][Full Text] [Related]
16. Increased dopamine receptor signaling and dopamine receptor-G protein coupling in denervated striatum.
Cai G; Wang HY; Friedman E
J Pharmacol Exp Ther; 2002 Sep; 302(3):1105-12. PubMed ID: 12183669
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D2 receptor-induced heterologous sensitization of adenylyl cyclase requires Galphas: characterization of Galphas-insensitive mutants of adenylyl cyclase V.
Watts VJ; Taussig R; Neve RL; Neve KA
Mol Pharmacol; 2001 Dec; 60(6):1168-72. PubMed ID: 11723222
[TBL] [Abstract][Full Text] [Related]
18. Plasticity of adenylyl cyclase-related signaling sequelae after long-term morphine treatment.
Shy M; Chakrabarti S; Gintzler AR
Mol Pharmacol; 2008 Mar; 73(3):868-79. PubMed ID: 18045853
[TBL] [Abstract][Full Text] [Related]
19. Activation of a novel PKC isoform synergistically enhances D2L dopamine receptor-mediated sensitization of adenylate cyclase type 6.
Beazely MA; Watts VJ
Cell Signal; 2005 May; 17(5):647-53. PubMed ID: 15683739
[TBL] [Abstract][Full Text] [Related]
20. Galphaq-coupled receptor signaling enhances adenylate cyclase type 6 activation.
Beazely MA; Watts VJ
Biochem Pharmacol; 2005 Jul; 70(1):113-20. PubMed ID: 15885660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
